MedTrace Logo

PAI-1 Expression in Non-scarring Hair Loss

NCT02548689 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 10

Last updated 2022-06-09

No results posted yet for this study

Summary

This study will investigate whether subjects who suffer from hair loss have increased levels of PAI-1 compared to age-matched control subjects. The level of PAI-1 expression will be determined in subjects without hair loss and in subjects with non-scarring hair loss, including androgenetic alopecia, telogen effluvium and alopecia areata.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Maria Colavincenzo, MD · Northwestern University Feinberg School of Medicine

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-07-31
Primary Completion
2021-06-30
Completion
2021-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02548689 on ClinicalTrials.gov